FilingReader Intelligence

Pulike Bio-Engineering reports mixed results: Earnings down, new strategy adopted

April 28, 2025 at 12:03 PM UTCBy FilingReader AI

** Pulike Biological Engineering (SSE:603566) reports a decrease in net profits for 2024, even as it navigates a dynamic market landscape. Net profits attributable to shareholders fell 46.82% to CNY92.81 million, while revenue increased 17.62% to CNY274.81 million. This, despite strategic moves like appointing a new accounting firm and outlining plans to increase efficiency.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

SSE:603566Shanghai Stock Exchange
Animal Health

News Alerts

Get instant email alerts when Pulike Biological Engineering publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →